Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round.
Bhavika K PatelMolly B CarnahanDonald W NorthfeltKaren AndersonGina L MazzaVictor J PizzitolaMarina E GiurescuRoxanne LoransWilliam G EversmanRichard E SharpeLaura K HarperHeidi ApseyPatricia CroninJuliana M KlingBrenda J ErnstJennifer PalmieriJessica FrakerLida MinaFelipe BataliniBarbara PockajPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
A pilot trial demonstrates a supplemental cancer detection rate of 23.9 per 1,000 in women at an elevated risk for breast cancer. Larger, multi-institutional, multiyear CEM trials in patients at elevated risk are needed for validation.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- diffusion weighted
- magnetic resonance
- computed tomography
- breast cancer risk
- diffusion weighted imaging
- papillary thyroid
- type diabetes
- squamous cell carcinoma
- skeletal muscle
- insulin resistance
- pregnancy outcomes
- real time pcr
- loop mediated isothermal amplification
- lymph node metastasis
- clinical evaluation